Information:
Error:
ID
20975
Description
Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423); ODM derived from: https://clinicaltrials.gov/show/NCT00724893
Link
https://clinicaltrials.gov/show/NCT00724893
Keywords
Versions (1)
- 4/1/17 4/1/17 -
Uploaded on
April 1, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C, Chronic NCT00724893
Eligibility Hepatitis C, Chronic NCT00724893
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT00724893
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Therapy naive | Hepatitis C, Chronic
Item
treatment-naïve patients with chronic hepatitis c
boolean
C0919936 (UMLS CUI [1])
C0524910 (UMLS CUI [2])
C0524910 (UMLS CUI [2])
Adult | Age
Item
adults (>18 years of age)
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
PegIntron Redipen prescribed
Item
prescribed pegetron redipen
boolean
C1962481 (UMLS CUI [1,1])
C0278329 (UMLS CUI [1,2])
C0278329 (UMLS CUI [1,2])
PegIntron Redipen Therapeutic procedure Compliance
Item
must meet all requirements for treatment with pegetron redipen
boolean
C1962481 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C3714738 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C3714738 (UMLS CUI [1,3])
Health Insurance Reimbursement Pharmaceutical Preparations
Item
must be able to obtain reimbursement of medication through private or provincial coverage
boolean
C0021684 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
Hepatitis B | Hepatitis B surface antigen positive
Item
active hepatitis b virus (hbv) infection (hepatitis b surface antigen [hbsag] positive)
boolean
C0019163 (UMLS CUI [1])
C0149709 (UMLS CUI [2])
C0149709 (UMLS CUI [2])
HIV antibody positive
Item
hiv antibody positive
boolean
C0920548 (UMLS CUI [1])
Transplantation of liver Status post
Item
post liver transplant patients
boolean
C0023911 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
C0231290 (UMLS CUI [1,2])
Exclusion Criteria Pharmaceutical Product Information
Item
any other exclusion criteria as per the product monograph
boolean
C0680251 (UMLS CUI [1,1])
C1709517 (UMLS CUI [1,2])
C1709517 (UMLS CUI [1,2])